HIV-1 Infection and Type 1 Interferon: Navigating Through Uncertain Waters (Q89589282)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29999412 AND SRC:MED&resulttype=core&format=json

6 April 2020

title

HIV-1 Infection and Type 1 Interferon: Navigating Through Uncertain Waters (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29999412 AND SRC:MED&resulttype=core&format=json

6 April 2020

author name string

Ashwin Balagopal

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29999412 AND SRC:MED&resulttype=core&format=json

6 April 2020

publication date

15 August 2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29999412 AND SRC:MED&resulttype=core&format=json

AIDS Research and Human Retroviruses

6 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29999412 AND SRC:MED&resulttype=core&format=json

6 April 2020

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29999412 AND SRC:MED&resulttype=core&format=json

6 April 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29999412 AND SRC:MED&resulttype=core&format=json

6 April 2020

page(s)

25-32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29999412 AND SRC:MED&resulttype=core&format=json

Interferon-alpha in patients with asymptomatic human immunodeficiency virus (HIV) infection. A randomized, placebo-controlled trial

6 April 2020

cites work

1 reference

12 December 2020

Anti-retroviral effects of interferon-alpha in AIDS-associated Kaposi's sarcoma

1 reference

12 December 2020

Latent infection of CD4 T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy

1 reference

12 December 2020

Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients

1 reference

12 December 2020

Type I Interferon Production Is Profoundly and Transiently Impaired in Primary HIV‐1 Infection

1 reference

12 December 2020

HIV-infected cells are major inducers of plasmacytoid dendritic cell interferon production, maturation, and migration

1 reference

12 December 2020

Innate antiviral response targets HIV-1 release by the induction of ubiquitin-like protein ISG15.

1 reference

12 December 2020

Cutting edge: enhancement of antibody responses through direct stimulation of B and T cells by type I IFN.

1 reference

12 December 2020

Effects of type I interferons on Friend retrovirus infection

1 reference

12 December 2020

Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5alpha restriction factor

1 reference

12 December 2020

Direct Stimulation of T Cells by Type I IFN Enhances the CD8 T Cell Response during Cross-Priming

1 reference

12 December 2020

Chronic CD4 T-cell activation and depletion in human immunodeficiency virus type 1 infection: type I interferon-mediated disruption of T-cell dynamics

1 reference

12 December 2020

HIV-1 accessory proteins VPR and Vif modulate antiviral response by targeting IRF-3 for degradation

1 reference

12 December 2020

Pegylated interferon-alpha 2a treatment of chronic SIV-infected macaques

1 reference

12 December 2020

Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu

1 reference

12 December 2020

Desensitization to type I interferon in HIV-1 infection correlates with markers of immune activation and disease progression

1 reference

12 December 2020

Diagnosis, management, and treatment of hepatitis C: an update

1 reference

12 December 2020

Human immunodeficiency virus type 1 mediates global disruption of innate antiviral signaling and immune defenses within infected cells

1 reference

12 December 2020

HIV-1 infection of macrophages is dependent on evasion of innate immune cellular activation

1 reference

12 December 2020

Nonpathogenic SIV infection of African green monkeys induces a strong but rapidly controlled type I IFN response

1 reference

12 December 2020

Hepatitis C virus blocks interferon effector function by inducing protein kinase R phosphorylation

1 reference

12 December 2020

Safety, tolerability, and mechanisms of antiretroviral activity of pegylated interferon Alfa-2a in HIV-1-monoinfected participants: a phase II clinical trial

1 reference

12 December 2020

Downregulation of robust acute type I interferon responses distinguishes nonpathogenic simian immunodeficiency virus (SIV) infection of natural hosts from pathogenic SIV infection of rhesus macaques

1 reference

12 December 2020

CD4 and CD8 T cell immune activation during chronic HIV infection: roles of homeostasis, HIV, type I IFN, and IL-7.

1 reference

12 December 2020

Innate sensing of HIV-infected cells

1 reference

12 December 2020

Management of adverse effects of Peg-IFN and ribavirin therapy for hepatitis C.

1 reference

12 December 2020

Vif hijacks CBF-β to degrade APOBEC3G and promote HIV-1 infection

1 reference

12 December 2020

Alpha interferon and HIV infection cause activation of human T cells in NSG-BLT mice

1 reference

12 December 2020

Interferon-alpha administration enhances CD8 T cell activation in HIV infection

1 reference

12 December 2020

Role of retroviral restriction factors in the interferon-α-mediated suppression of HIV-1 in vivo

1 reference

12 December 2020

SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates

1 reference

12 December 2020

Modulation of T-cell function by type I interferon

1 reference

12 December 2020

APOBEC3G-induced hypermutation of human immunodeficiency virus type-1 is typically a discrete "all or nothing" phenomenon

1 reference

12 December 2020

Treatment of SIV-infected sooty mangabeys with a type-I IFN agonist results in decreased virus replication without inducing hyperimmune activation

1 reference

12 December 2020

Vpu mediates depletion of interferon regulatory factor 3 during HIV infection by a lysosome-dependent mechanism

1 reference

12 December 2020

Vpu-deficient HIV strains stimulate innate immune signaling responses in target cells

1 reference

12 December 2020

HIV-1 infection of human macrophages directly induces viperin which inhibits viral production.

1 reference

12 December 2020

Plasmacytoid dendritic cells in HIV infection

1 reference

12 December 2020

Codon-usage-based inhibition of HIV protein synthesis by human schlafen 11

1 reference

12 December 2020

Pegylated Interferon alfa-2a monotherapy results in suppression of HIV type 1 replication and decreased cell-associated HIV DNA integration

1 reference

12 December 2020

Innate sensing of HIV-1 assembly by Tetherin induces NFκB-dependent proinflammatory responses.

1 reference

12 December 2020

Interferon-α is the primary plasma type-I IFN in HIV-1 infection and correlates with immune activation and disease markers

1 reference

12 December 2020

HIV-1 Vpu does not degrade interferon regulatory factor 3.

1 reference

12 December 2020

Blockade of chronic type I interferon signaling to control persistent LCMV infection

1 reference

12 December 2020

Persistent LCMV infection is controlled by blockade of type I interferon signaling

1 reference

12 December 2020

Vpu binds directly to tetherin and displaces it from nascent virions

1 reference

12 December 2020

Cyclic GMP-AMP synthase is an innate immune sensor of HIV and other retroviruses

1 reference

12 December 2020

Intact type I Interferon production and IRF7 function in sooty mangabeys

1 reference

12 December 2020

Human MX2 is an interferon-induced post-entry inhibitor of HIV-1 infection

1 reference

12 December 2020

IFI16 senses DNA forms of the lentiviral replication cycle and controls HIV-1 replication.

1 reference

12 December 2020

HIV-1 evades innate immune recognition through specific cofactor recruitment

1 reference

12 December 2020

Replication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure.

1 reference

12 December 2020

Relative resistance of HIV-1 founder viruses to control by interferon-alpha

1 reference

12 December 2020

Innate antiviral immune signaling, viral evasion and modulation by HIV-1.

1 reference

12 December 2020

Expansion of HAART coverage is associated with sustained decreases in HIV/AIDS morbidity, mortality and HIV transmission: the "HIV Treatment as Prevention" experience in a Canadian setting

1 reference

12 December 2020

Type I interferon responses in rhesus macaques prevent SIV infection and slow disease progression

1 reference

12 December 2020

Plasmacytoid dendritic cells suppress HIV-1 replication but contribute to HIV-1 induced immunopathogenesis in humanized mice

1 reference

12 December 2020

HIV-1 Vpu accessory protein induces caspase-mediated cleavage of IRF3 transcription factor

1 reference

12 December 2020

Modulation of type I interferon-associated viral sensing during acute simian immunodeficiency virus infection in African green monkeys

1 reference

12 December 2020

Type I interferon: understanding its role in HIV pathogenesis and therapy

1 reference

12 December 2020

HIV Blocks Interferon Induction in Human Dendritic Cells and Macrophages by Dysregulation of TBK1

1 reference

12 December 2020

Plasmacytoid Dendritic Cell Infection and Sensing Capacity during Pathogenic and Nonpathogenic Simian Immunodeficiency Virus Infection

1 reference

12 December 2020

HIV-1 and interferons: who's interfering with whom?

1 reference

12 December 2020

Blockade of interferon Beta, but not interferon alpha, signaling controls persistent viral infection

1 reference

12 December 2020

HIV Vpu Interferes with NF-κB Activity but Not with Interferon Regulatory Factor 3.

1 reference

12 December 2020

Heterosexual Transmission of Subtype C HIV-1 Selects Consensus-Like Variants without Increased Replicative Capacity or Interferon-α Resistance

1 reference

12 December 2020

Short-term Treatment With Interferon Alfa Diminishes Expression of HIV-1 and Reduces CD4 T-Cell Activation in Patients Coinfected With HIV and Hepatitis C Virus and Receiving Antiretroviral Therapy

1 reference

12 December 2020

Prevention of SHIV transmission by topical IFN-β treatment

1 reference

12 December 2020

Interferon Alpha Subtype-Specific Suppression of HIV-1 Infection In Vivo

1 reference

12 December 2020

Accumulation of MxB/Mx2-resistant HIV-1 Capsid Variants During Expansion of the HIV-1 Epidemic in Human Populations

1 reference

12 December 2020

Defective proviruses rapidly accumulate during acute HIV-1 infection

1 reference

12 December 2020

Vpu-Mediated Counteraction of Tetherin Is a Major Determinant of HIV-1 Interferon Resistance

1 reference

12 December 2020

Type I interferon responses are impaired in latently HIV infected cells.

1 reference

12 December 2020

Resistance of Transmitted Founder HIV-1 to IFITM-Mediated Restriction.

1 reference

12 December 2020

Type I interferon suppresses virus-specific B cell responses by modulating CD8( ) T cell differentiation

1 reference

12 December 2020

Targeting type I interferon-mediated activation restores immune function in chronic HIV infection

1 reference

12 December 2020

Blocking type I interferon signaling enhances T cell recovery and reduces HIV-1 reservoirs

1 reference

12 December 2020

Resistance to type 1 interferons is a major determinant of HIV-1 transmission fitness

1 reference

12 December 2020

Intracellular HIV-1 RNA and CD4 T-cell activation in patients starting antiretrovirals.

1 reference

12 December 2020

Type I interferons suppress viral replication but contribute to T cell depletion and dysfunction during chronic HIV-1 infection

1 reference

12 December 2020

HIV-antibody complexes enhance production of type I interferon by plasmacytoid dendritic cells

1 reference

12 December 2020

Deep sequencing of HIV-1 reverse transcripts reveals the multifaceted antiviral functions of APOBEC3G.

1 reference

12 December 2020

Pegylated IFN-α-induced NK cell activation is associated with HIV-1 DNA decline in ART-treated HIV-1/HCV co-infected patients.

1 reference

12 December 2020

Reduced Chronic Lymphocyte Activation following Interferon Alpha Blockade during the Acute Phase of Simian Immunodeficiency Virus Infection in Rhesus Macaques.

1 reference

12 December 2020

No Effect of Pegylated Interferon-alpha on Total Hiv-1 DNA Load in HIV-1/HCV Coinfected Patients.

1 reference

12 December 2020

The involvement of plasmacytoid cells in HIV infection and pathogenesis.

1 reference

12 December 2020

Short-term pIFN-α2a treatment does not significantly reduce the viral reservoir of SIV-infected, ART-treated rhesus macaques.

1 reference

12 December 2020

HIV-1 Activation of Innate Immunity Depends Strongly on the Intracellular Level of TREX1 and Sensing of Incomplete Reverse Transcription Products

1 reference

12 December 2020

Identifiers

DOI

10.1089/AID.2018.0161

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29999412 AND SRC:MED&resulttype=core&format=json

6 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29999412 AND SRC:MED&resulttype=core&format=json

6 April 2020

PubMed publication ID

29999412

1 reference